Search the NLPDP Drug Product Database

Drug Information


Brand Name:
Brand Name
This is the name under which the drug product is marketed.
CIPRALEX 10MG TABLET
Generic Name: escitalopram oxalate
Strength:
Strength
This refers to the amount of the active (medicinal) ingredient (e.g., 50mg, 10 mg/5 mL).
10 mg
DIN:
DIN
A Drug Identification Number (DIN) is an eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada.

A DIN uniquely identifies the following product characteristics: manufacturer; product name; active ingredient(s); strength(s) of active ingredient(s); pharmaceutical form; route of administration.
02263238
Dosage Form:
Dosage Form
The pharmaceutical dosage form is the form of presentation in which the product is supplied for example (e.g.) tablet, capsule, powder, etc..
TABLET
Manufacturer: LUNDBECK CANADA
Benefit Status:
Benefit Status
Open - Drugs which are reimbursed with no criteria or prior approval. Note: a drug may have limitations that restrict usage.
Special Authorization - Drugs which are only eligible for reimbursement when a Beneficiary meets specific criteria recommended by the Atlantic Common Drug Review (ACDR), the National Common Drug Review (CDR) or the Joint Oncology Drug Review (JODR) Committees.
OPEN
Limitations:
Limitations
Drugs which are restricted to those individuals who meet the defined restriction requirements. Eg. Limitation based on age such as children under 12 years of age.
Initial fills are limited to a maximum 30 days. Maximum of 1.5 tablets daily.
Pricing:
Pricing
Pricing for the Newfoundland and Labrador Prescription Drug Program is based upon Defined Cost which is the current published manufacturer’s list price for a drug plus 8.5% (unless otherwise specified).
Package Size        NLPDP List Price Per Unit
30 2.409
100 2.409
Interchangeable Drug Products
Interchangeable Drug Products
Interchangeable drug products means pharmaceutical equivalents or pharmaceutical alternatives that are the therapeutic equivalents of and that have the same route of administration as a reference product. The Newfoundland and Labrador Interchangeable Drug Products Formulary (NIDPF) is a list of commonly used drugs which have therapeutic equivalence to a reference product.
MINT-ESCITALOPRAM 10 MG TABLET
ESCITALOPRAM 10 MG TABLET
ESCITALOPRAM 10 MG TABLET
ACH-ESCITALOPRAM 10 MG TABLET
MAR-ESCITALOPRAM 10 MG TABLET
ESCITALOPRAM 10 MG TABLET
NAT-ESCITALOPRAM 10 MG TABLET
PMS-ESCITALOPRAM 10 MG TAB
APO-ESCITALOPRAM 10 MG TABLET
M-ESCITALOPRAM 10 MG TABLET
NRA-ESCITALOPRAM 10 MG TABLET
MYLAN-ESCITALOPRAM 10 MG TAB
TEVA-ESCITALOPRAM 10 MG TABLET
SANDOZ ESCITALOPRAM 10 MG TAB
JAMP-ESCITALOPRAM 10 MG TABLET
TARO-ESCITALOPRAM 10 MG TABLET
AURO-ESCITALOPRAM 10 MG TABLET
Interchangeable Unit Price
Interchangeable Unit Price
Interchangeable Unit Price – the lowest unit price of all drug products within an NIDPF category.
0.3389
ATC
ATC
The Anatomical Therapeutic Chemical (ATC) is a classification system, where the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.
N06AB10 - ESCITALOPRAM

Return to NLPDP Drug Database Search Page